Markt oder Branche auswählen:
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
Aktuell sind keine Nachrichten verfügbar, die den gewählten Kriterien entsprechen. | |||||
| Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
|---|---|---|---|---|---|
| ALVOTECH A3DK8U Frankfurt | 4,390 4,780 | 0,000 0,00 % | 13.11. | ||
| AMAROQ LTD A41AT8 Tradegate | 1,050 1,040 | +0,010 +0,96 % | 07:30 | ||
| ARION BANK HF SDR A2JNAX Frankfurt | 1,165 1,170 | 0,000 0,00 % | 13.11. | ||
| JBT MAREL CORPORATION A0Q6F9 Tradegate | 123,000 124,00 | +4,00 +3,36 % | 11.11. | ||
| OCULIS HOLDING AG A3D8QG Frankfurt | 15,600 17,000 | 0,000 0,00 % | 13.11. |
06.11.
Icelandair carried a total of 464 thousand passengers in October, a 14% increase year-over-year. The growth was strong in the market to Iceland, where passenger numbers rose by 20% and in the market from Iceland, which grew by 31%. Of all passengers...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
02.11.
REYKJAVIK, ICELAND (November 2, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug Administration (FDA)...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Mi
Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine months compared to the same period last yearLicense...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Di
Highlights of Q3 2025 results Overall, the Company's operations were below expectations in the third quarter. Volumes in Liner were decent during the quarter, increasing by 1.5%, but average freight rates declined compared to the same period last...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
06.11.
REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ("Advanz Pharma")...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .